103 related articles for article (PubMed ID: 7058458)
1. Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.
Berger GM; Van der Westhuyzen JH; Huskisson J; Bonnici F; Henderson HE
S Afr Med J; 1982 Feb; 61(8):266-72. PubMed ID: 7058458
[TBL] [Abstract][Full Text] [Related]
2. Why very low density lipoprotein levels are normal in familial hyperchylomicronaemia.
Berger GM
Atherosclerosis; 1979 Sep; 34(1):83-6. PubMed ID: 227432
[TBL] [Abstract][Full Text] [Related]
3. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
Brunzell JD; Hazzard WR; Porte D; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
[TBL] [Abstract][Full Text] [Related]
5. Modifications of plasma lipoproteins after lipase activation in patients with chylomicronemia.
Manzato E; Zambon S; Marin R; Baggio G; Crepaldi G
J Lipid Res; 1986 Dec; 27(12):1248-58. PubMed ID: 3559389
[TBL] [Abstract][Full Text] [Related]
6. Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
Kondo Y; Kurobane I; Omura K; Sano R; Abe R; Chida N; Tada K
Tohoku J Exp Med; 1985 Jan; 145(1):1-6. PubMed ID: 3983953
[TBL] [Abstract][Full Text] [Related]
7. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
[TBL] [Abstract][Full Text] [Related]
8. Familial hyperchylomicronaemia in four families. Problems in diagnosis, management, and aetiology reviewed.
Berger GM; Bonnici F
S Afr Med J; 1977 Apr; 51(18):623-8. PubMed ID: 867182
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of type I hyperlipoproteinemia.
Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
[No Abstract] [Full Text] [Related]
10. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
Liu G; Excoffon KJ; Wilson JE; McManus BM; Miao L; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME
Clin Invest Med; 1998; 21(4-5):172-85. PubMed ID: 9800066
[TBL] [Abstract][Full Text] [Related]
11. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
12. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
[TBL] [Abstract][Full Text] [Related]
13. Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities.
Berger GM
Metabolism; 1986 Nov; 35(11):1054-61. PubMed ID: 3773723
[TBL] [Abstract][Full Text] [Related]
14. The lipid-lowering effect of dietary proanthocyanidins in rats involves both chylomicron-rich and VLDL-rich fractions.
Quesada H; Díaz S; Pajuelo D; Fernández-Iglesias A; Garcia-Vallvé S; Pujadas G; Salvadó MJ; Arola L; Bladé C
Br J Nutr; 2012 Jul; 108(2):208-17. PubMed ID: 22011563
[TBL] [Abstract][Full Text] [Related]
15. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.
Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW
Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035
[TBL] [Abstract][Full Text] [Related]
16. Chylomicronaemia in multiple myeloma.
Aviram M; Carter A; Brook JG; Tatarsky I
Scand J Haematol; 1985 May; 34(5):436-41. PubMed ID: 4012223
[TBL] [Abstract][Full Text] [Related]
17. Influence of lipolysis on chylomicron clearance and HDL cholesterol levels.
Patsch J
Eur Heart J; 1998 Jul; 19 Suppl H():H2-6. PubMed ID: 9717057
[TBL] [Abstract][Full Text] [Related]
18. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790
[TBL] [Abstract][Full Text] [Related]
19. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
20. Selective protamine sulphate inactivation of lipoprotein lipase and hepatic lipase in human post-heparin plasma: specific lipase levels in normals and in type I hyperlipoproteinaemia.
Berger GM; Abraham PR
Clin Chim Acta; 1977 Dec; 81(3):219-28. PubMed ID: 923094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
